Aug 2026
Plasma pro-c3 as a surrogate indicator of steatosis and fibrosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD): A case-control study
Plasma PRO-C3 shows promise as a non-invasive biomarker for detecting both steatosis and fibrosis in MAFLD patients.
H. Faheem, H. Badawy, K. Raafat et al.
· The Quarterly journal of med... · 0 citations